Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 11Carcinoma, Ovarian Epithelial 4Small Cell Lung Carcinoma 2Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Platinum-resistant Ovarian Cancer 1Pancreatic Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Nausea 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Kenny-Caffey syndrome, Type 1 1Gonadal Disorders 1Glioblastoma 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endometrial Neoplasms 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1

Interventions

Fluorouracil 5Paclitaxel 3Mitomycin 3Capecitabine 3fludarabine 2Radiotherapy 2Radiation 2Cyclophosphamide 2Cisplatin 2Carboplatin 2niraparib 1dehydroftorafur 1avelumab 1Taxes 1Ritonavir 1Probiotics 1Prebiotics 1Platinum 1Oxaliplatin 1Mitomycins 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin-2 1Indinavir 1Immune Checkpoint Inhibitors 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Diathermy 1Chemoradiotherapy 1Cetuximab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Anus Neoplasms × niraparib × Clear all
NCT03221400 2022-02-17

PEN-866 in Patients With Advanced Solid Malignancies

Tarveda Therapeutics

Phase 1/2 Unknown
340 enrolled
GastrointestinalThoracic

Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡